AI assistant
Sending…
Skye Bioscience, Inc. — Director's Dealing 2020
Oct 7, 2020
34097_dirs_2020-10-07_a332a8ae-4d38-45b8-82af-d8b32b4ab487.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Emerald Bioscience, Inc. (EMBI)
CIK: 0001516551
Period of Report: 2020-09-25-05:00
Reporting Person: Janney Richard (N/A)
More from Skye Bioscience, Inc.
Declaration of Voting Results & Voting Rights Announcements
2026
May 29
Delisting Announcement
2026
May 15
Annual Report
2026
Apr 16
Proxy Solicitation & Information Statement
2026
Apr 16
Board/Management Information
2026
Apr 3
Delisting Announcement
2026
Mar 19
Board/Management Information
2026
Feb 20
Director's Dealing
2026
Feb 10
Director's Dealing
2026
Feb 10
Director's Dealing
2026
Feb 10